Assessment of weight gain in adult patients living with HIV receiving first‐line dolutegravir‐based or efavirenz‐based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study
HIV Medicine · 2024
DOI: 10.1111/hiv.13638 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift HIV Medicine, 2024. Verfasst von Shobna Sawry und 13 weiteren Autor:innen. Beteiligte Einrichtung: Wits RHI, University of the Witwatersrand, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Weight Gain, HIV Infections, Pyridones, Heterocyclic Compounds, 3-Ring. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CDC HHS, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Introduction
Although dolutegravir (DTG) is deemed stable, safe, cost‐effective, and clinically beneficial, it also carries the risk of side effects, including observed weight gain among patients on DTG ‐based antiretroviral therapy ( ART ) regimens. We compared weight changes among adults (≥18 years) initiating tenofovir disoproxil fumarate, lamivudine, and dolutegravir ( TLD ) or tenofovir disoproxil fumarate, emtricitabine, and efavirenz ( TEE) regimens and those switching from TEE to TLD ( TEE‐to‐TLD switchers) in three large primary care facilities in South Africa Methods We conducted a retrospective longitudinal record review using patient medical records, extracting relevant demographic and clinical data from October 2018 to June 2021 from randomly selected adults who initiated TLD or TEE (initiators) and adult TEE‐to‐TLD switchers. We assessed weight, body mass index ( BMI ), and percentage weight changes for both groups and fitted linear regression and generalized linear models to determine factors associated with weight and BMI change and percentage weight change ≥10%, respectively, among treatment initiators. We fitted linear mixed‐effect models among TEE‐to‐TLD switchers to consider repeated measures.
Results
Of 860 initiators, 450 (52.3%) initiated on TEE and 410 (47.7%) on TLD , with median follow‐up of 1.4 years and 1.0 year, respectively. At initiation, 43.3% on TEE and 40.8% on TLD were overweight or obese. TLD initiators had an adjusted higher mean weight gain of 1.6 kg ( p < 0.001) and mean BMI gain of 0.51 kg/m 2 ( p < 0.001) than TEE initiators. Independent risk factors for higher mean weight and BMI included age ≥50 years, male, on ART for >12 months, initial BMI of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wits RHI, University of the Witwatersrand, Johannesburg, South Africa.
- Division of Global HIV and TB, Centers for Disease Control and Prevention (CDC), Pretoria, South Africa.
- Division of Global HIV and TB, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
ORCID-Profile: Shobna Sawry
Förderung
- CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Sawry, S., Ayalew, K., Maimela, G., Briggs-Hagen, M., van Wyk-Heath, M., Mthethwa, S., Shai, S., Mngomezulu, N. N., Tlhowe, L., Achere-Darko, J., Bedford, J., Martin, C. E., Fairlie, L., & Imrie, J. (2024). Assessment of weight gain in adult patients living with HIV receiving first‐line dolutegravir‐based or efavirenz‐based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study. HIV Medicine. https://doi.org/10.1111/hiv.13638
Vancouver
Sawry S, Ayalew K, Maimela G, Briggs-Hagen M, van Wyk-Heath M, Mthethwa S, et al. Assessment of weight gain in adult patients living with HIV receiving first‐line dolutegravir‐based or efavirenz‐based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study. HIV Medicine. 2024. doi:10.1111/hiv.13638
BibTeX
@article{Sawry2024,
author = {Sawry, Shobna and Ayalew, Kassahun and Maimela, Gloria and Briggs-Hagen, Melissa and van Wyk-Heath, Marelize and Mthethwa, Simangele and Shai, Sannie and Mngomezulu, Nkululeko N and Tlhowe, Lawrence and Achere-Darko, Josephine and Bedford, Jason and Martin, Catherine E and Fairlie, Lee and Imrie, John},
title = {Assessment of weight gain in adult patients living with HIV receiving first‐line dolutegravir‐based or efavirenz‐based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study},
journal = {HIV Medicine},
year = {2024},
doi = {10.1111/hiv.13638}
}
EUVIMED